Have a feature idea you'd love to see implemented? Let us know!

AEMD Aethlon Medical Inc

Price (delayed)

$0.3928

Market cap

$5.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.84

Enterprise value

-$2.85M

Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier ...

Highlights
Aethlon Medical's EPS has increased by 30% YoY and by 21% QoQ
The company's debt fell by 7% QoQ
The company's equity has surged by 51% QoQ but it fell by 34% YoY
The quick ratio has grown by 42% from the previous quarter but it has contracted by 40% YoY
Aethlon Medical's gross profit has shrunk by 100% YoY
AEMD's revenue has plunged by 100% YoY

Key stats

What are the main financial stats of AEMD
Market
Shares outstanding
13.94M
Market cap
$5.47M
Enterprise value
-$2.85M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.63
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$11.5M
EBITDA
-$11.14M
Free cash flow
-$9.42M
Per share
EPS
-$3.84
Free cash flow per share
-$1.26
Book value per share
$0.63
Revenue per share
$0
TBVPS
$1.53
Balance sheet
Total assets
$11.42M
Total liabilities
$2.7M
Debt
$869,945
Equity
$8.71M
Working capital
$7.42M
Liquidity
Debt to equity
0.1
Current ratio
4.49
Quick ratio
4.32
Net debt/EBITDA
0.75
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-107.1%
Return on equity
-141.9%
Return on invested capital
-861.3%
Return on capital employed
-123.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AEMD stock price

How has the Aethlon Medical stock price performed over time
Intraday
-1.06%
1 week
-8.88%
1 month
5.85%
1 year
-78.06%
YTD
-82.06%
QTD
-15.78%

Financial performance

How have Aethlon Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.85M
Net income
-$11.5M
Gross margin
N/A
Net margin
N/A
Aethlon Medical's gross profit has shrunk by 100% YoY
AEMD's revenue has plunged by 100% YoY
The net income has increased by 7% year-on-year and by 6% since the previous quarter
The company's operating income rose by 6% QoQ and by 4.5% YoY

Growth

What is Aethlon Medical's growth rate over time

Valuation

What is Aethlon Medical stock price valuation
P/E
N/A
P/B
0.63
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aethlon Medical's EPS has increased by 30% YoY and by 21% QoQ
The P/B is 52% below the 5-year quarterly average of 1.3 and 10% below the last 4 quarters average of 0.7
The company's equity has surged by 51% QoQ but it fell by 34% YoY
AEMD's revenue has plunged by 100% YoY

Efficiency

How efficient is Aethlon Medical business performance
The ROE has plunged by 87% YoY and by 7% from the previous quarter
The ROA has plunged by 66% YoY and by 3.8% from the previous quarter
Aethlon Medical's ROIC has decreased by 40% YoY and by 9% from the previous quarter

Dividends

What is AEMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AEMD.

Financial health

How did Aethlon Medical financials performed over time
The quick ratio has grown by 42% from the previous quarter but it has contracted by 40% YoY
Aethlon Medical's current ratio has decreased by 39% YoY but it has increased by 32% QoQ
The company's debt is 90% lower than its equity
The company's equity has surged by 51% QoQ but it fell by 34% YoY
The debt to equity has increased by 43% year-on-year but it has declined by 38% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.